Shares of Diploma PLC (LON:DPLM - Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 4,287.14 ($57.73) and traded as high as GBX 4,720 ($63.56). Diploma shares last traded at GBX 4,716 ($63.51), with a volume of 235,972 shares traded.
Diploma Trading Down 0.0%
The company's fifty day moving average is GBX 4,320.16 and its two-hundred day moving average is GBX 4,295.76. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. The stock has a market cap of £6.38 billion, a price-to-earnings ratio of 54.97, a PEG ratio of 2.82 and a beta of 0.75.
Diploma (LON:DPLM - Get Free Report) last announced its quarterly earnings data on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) EPS for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, research analysts predict that Diploma PLC will post 163.7995512 EPS for the current fiscal year.
Insider Buying and Selling
In other Diploma news, insider Ian El-Mokadem bought 500 shares of the firm's stock in a transaction that occurred on Monday, March 24th. The stock was purchased at an average price of GBX 3,948 ($53.16) per share, for a total transaction of £19,740 ($26,582.28). Also, insider Katie Bickerstaffe purchased 44 shares of the company's stock in a transaction on Wednesday, May 21st. The stock was bought at an average price of GBX 4,867 ($65.54) per share, for a total transaction of £2,141.48 ($2,883.76). Over the last quarter, insiders bought 596 shares of company stock worth $2,447,173. Corporate insiders own 0.52% of the company's stock.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
